Literature DB >> 17557316

The relationship between quality of life and levels of hopelessness and depression in palliative care.

Kyriaki Mystakidou1, Eleni Tsilika, Efi Parpa, Maria Pathiaki, Antonis Galanos, Lambros Vlahos.   

Abstract

There is growing interest in the psychological distress and quality of life of cancer patients. The aim of this study was to compare the responses of 102 advanced cancer patients on a quality of life scale (as measured by the SF12) with the Beck Depression Inventory (BDI) and the Beck Hopelessness Scale (BHS), as well as the impact of depression and hopelessness on quality of life. Significant associations were found between gender (P=.027), performance status (P=.003), opioids (P=.002), depression (P<.0005), and hopelessness (P<.0005) with the SF12-Mental Component Score (MCS). Gender (P=.07), metastasis (P=.001), opioids (P=.0005), and education (P=.045) correlated significantly with SF12-Physical Component Score (PCS). In the prediction of MCS, the dimensions of age, hopelessness, gender, and performance status were statistically significantly high (P<.0005), explaining 48% of variance. For PCS, the predictor variables were education, metastasis, and opioids (25% of variance). Quality of life, in this patient population, was predicted by the level of hopelessness and patients' demographic and clinical characteristics. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17557316     DOI: 10.1002/da.20319

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  8 in total

1.  Depression and Charcot-Marie-Tooth disease.

Authors:  P Vinci; P Gargiulo; G B Colazza
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

2.  Advanced cancer as a risk for major depressive episodes.

Authors:  Fremonta Meyer; Kalen Fletcher; Holly G Prigerson; Ilana M Braun; Paul K Maciejewski
Journal:  Psychooncology       Date:  2014-11-12       Impact factor: 3.894

3.  Measuring individual quality of life in patients receiving radiation therapy: the SEIQoL-Questionnaire.

Authors:  Gerhild Becker; Constanze S Merk; Cornelia Meffert; Felix Momm
Journal:  Qual Life Res       Date:  2014-03-01       Impact factor: 4.147

4.  Trajectories of quality of life among Chinese patients diagnosed with nasopharynegeal cancer.

Authors:  Wendy W T Lam; Michelle Ye; Richard Fielding
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Resilience and hope during advanced disease: a pilot study with metastatic colorectal cancer patients.

Authors:  Joao Paulo Consentino Solano; Amanda Gomes da Silva; Ivan Agurtov Soares; Hazem Adel Ashmawi; Joaquim Edson Vieira
Journal:  BMC Palliat Care       Date:  2016-08-02       Impact factor: 3.234

6.  Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis.

Authors:  Ling-Chun Lu; Shiow-Luan Tsay; Sou-Yi Chang; Chung-Ming Chen; Chieh-Yu Liu
Journal:  Cancer Med       Date:  2019-02-11       Impact factor: 4.452

7.  Determine the Symptom Intensities, Performance and Hopelessness Levels of Advanced Lung Cancer Patients for the Palliative Care Approach.

Authors:  Esra Dogan; Hanife Ozcelik
Journal:  Am J Hosp Palliat Care       Date:  2022-03-02       Impact factor: 2.090

8.  Assessment of Psychological Distress and its Effect on Quality of Life and Social Functioning in Cancer Patients.

Authors:  Gunaseelan Karunanithi; Rapole Pragna Sagar; Aswin Joy; Parthasarathy Vedasoundaram
Journal:  Indian J Palliat Care       Date:  2018 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.